The sample copy of this report is available for access.
The North America Spirometer Market is expected to reach USD 521.6 million by 2032, growing at a CAGR of 7.6% during (2026 - 2033).
The North America Spirometer Market evolved from mechanical pulmonary function testing systems primarily used in hospital laboratories into digital, portable, and increasingly connected diagnostic solutions. Improvements in sensor technology, electronic measurement, handheld designs, and software-based analysis broadened spirometry use across hospitals, clinics, diagnostic centers, and homecare environments. Increasing recognition of COPD, asthma, and other respiratory conditions strengthened the role of lung-function testing in disease diagnosis and monitoring. The market now combines compact devices, digital connectivity, remote monitoring, advanced analytics, and healthcare-system integration to support more accessible respiratory assessment.
Connected spirometry, home-based monitoring, artificial intelligence, and digital health integration are reshaping the market. Portable and Bluetooth-enabled devices support remote respiratory assessment and reduce dependence on specialized testing environments, while integration with electronic health records and cloud platforms improves longitudinal patient management. AI-assisted interpretation and automated quality assessment are enhancing diagnostic workflows, and improved sensor precision is supporting more reliable measurements. Regulatory emphasis on standardized testing, clinical validation, interoperability, data security, and device accuracy is also encouraging manufacturers to develop increasingly sophisticated respiratory diagnostic platforms.
Based on Type, the market is segmented into Volume Measurement and Peak Flow Meters. The Volume Measurement market dominated the North America Spirometer Market by Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 364.6 million by 2032, growing at a CAGR of 7.3 % during the forecast period. The Peak Flow Meters market is expected to witness a CAGR of 8.2% during (2026 - 2033).
Volume Measurement spirometers provide detailed assessment of lung volumes and airflow parameters, supporting diagnosis, disease staging, treatment evaluation, and longitudinal respiratory monitoring across hospitals, specialty clinics, and diagnostic centers. Their development increasingly emphasizes portable formats, digital connectivity, cloud-based data management, and compatibility with electronic health records. Peak Flow Meters provide simpler and more affordable measurement of peak expiratory flow, supporting routine asthma monitoring and self-management. Their portability, straightforward operation, digital variants, and suitability for home and outpatient use sustain demand where frequent airflow monitoring is required.
Based on Product Type, the market is segmented into Devices, Accessories & Consumables, and Software. The Devices market dominated the North America Spirometer Market by Product Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 289.3 million by 2032, growing at a CAGR of 7.2 % during the forecast period. The Accessories & Consumables market is expected to witness a CAGR of 7.8% during (2026 - 2033). The Software market is expected to witness a CAGR of 8.4% during (2026 - 2033).
Devices include conventional, digital, portable, and handheld spirometry systems used across hospitals, diagnostic centers, physician practices, specialty respiratory clinics, and homecare settings. Accessories & Consumables include mouthpieces, bacterial and viral filters, nose clips, tubing, flow sensors, calibration products, and other recurring components necessary for hygienic and standardized testing. Software supports pulmonary calculations, automated interpretation, quality assessment, reporting, patient-data storage, trend analysis, EHR connectivity, remote monitoring, and cloud-based respiratory management. Increasing AI integration and digital healthcare adoption are strengthening software's strategic role within connected spirometry systems.
Based on Application, the market is segmented into Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Other Applications. COPD applications rely on spirometry for diagnosis, severity assessment, therapeutic monitoring, and tracking changes in lung function, with connected devices increasingly supporting remote disease management.
Asthma applications use lung-function measurements to evaluate variable airflow obstruction, treatment response, and respiratory symptoms across primary care, allergy, and pulmonary settings. Other Applications include interstitial lung diseases, pulmonary fibrosis, cystic fibrosis, preoperative respiratory assessment, occupational health screening, clinical trials, and other specialized pulmonary evaluations where objective respiratory measurements support diagnosis, monitoring, or risk assessment.
Based on End User, the market is segmented into Hospitals, Physician & Clinics, Diagnostic Centers, Homecare Settings, and Other Facilities. Hospitals use spirometers across inpatient, outpatient, preoperative, chronic respiratory, and research settings where accuracy, reliability, and interoperability are important. Physician & Clinics support routine screening and repeat lung-function assessment with portable and easy-to-use systems, while Diagnostic Centers emphasize standardized and reproducible testing for referred patients and specialized respiratory evaluations.
Homecare Settings are expanding through wireless connectivity, telehealth, remote monitoring, and patient-friendly devices that enable repeated testing outside clinical facilities. Other Facilities include occupational health programs, rehabilitation centers, academic institutions, and specialized community care environments requiring targeted pulmonary assessment.
Free Valuable Insights: The Global Spirometer Market will hit USD 1511.6 Million billion by 2033, at a CAGR of 7.9%
Based on Country, the market is segmented into US, Canada, Mexico, and Rest of North America. The US market dominated the North America Spirometer Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 400.2 million by 2032, growing at a CAGR of 6.9 % during the forecast period. The Canada market is expected to witness a CAGR of 10.1% during (2026 - 2033). Additionally, The Mexico market is expected to witness a CAGR of 9.3% during (2026 - 2033).
Across North America, spirometer adoption is being shaped by digital health, early respiratory disease detection, connected monitoring, device accuracy, and regulatory standardization. The US emphasizes portable and connected spirometry, AI-assisted interpretation, remote patient monitoring, interoperability, and stringent compliance, while Canada combines cloud connectivity, affordability, portable diagnostics, advanced sensors, and localized healthcare integration. Mexico is progressing through broader respiratory screening, digital and wireless devices, AI-enabled analysis, telemedicine, and localized clinical adoption, whereas Rest of North America continues to expand home monitoring, advanced sensor technologies, standardized testing, cloud connectivity, and integrated respiratory care solutions.
By Type
By Product Type
By Application
By End User
By Country
Set to reach $521.6 Million by 2032, growing at 7.6% CAGR during 2026-2033.
The US leads with $400.2 million by 2032, growing at 6.9% CAGR during the forecast period.
Rising demand for Volume Measurement spirometers, reaching $364.6 million by 2032 at 7.3% CAGR.
Devices segment to achieve $289.3 million by 2032, growing at 7.2% CAGR during the forecast period.
Canada's spirometer market is expected to witness a CAGR of 10.1% during 2026-2033.
The Software segment is expected to grow at 8.4% CAGR during 2026-2033.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 